Champions Oncology, Inc. (CSBR)
4.93
-0.09
(-1.79%)
USD |
NASDAQ |
Aug 28, 16:00
5.115
+0.18
(+3.75%)
After-Hours: 20:00
Champions Oncology Free Cash Flow : -5.036M for April 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| April 30, 2026 | -5.036M |
| January 31, 2026 | 3.816M |
| October 31, 2025 | 5.64M |
| July 31, 2025 | 7.24M |
| April 30, 2025 | 6.997M |
| January 31, 2025 | -1.323M |
| October 31, 2024 | -2.816M |
| July 31, 2024 | -2.003M |
| April 30, 2024 | -6.973M |
| January 31, 2024 | -6.72M |
| October 31, 2023 | -4.856M |
| July 31, 2023 | -2.61M |
| April 30, 2023 | 1.10M |
| January 31, 2023 | 2.842M |
| October 31, 2022 | 5.875M |
| July 31, 2022 | 3.855M |
| April 30, 2022 | 4.113M |
| January 31, 2022 | 0.989M |
| October 31, 2021 | -3.931M |
| July 31, 2021 | -4.22M |
| April 30, 2021 | -4.962M |
| January 31, 2021 | -1.11M |
| October 31, 2020 | 0.066M |
| July 31, 2020 | 0.28M |
| April 30, 2020 | 0.685M |
| Date | Value |
|---|---|
| January 31, 2020 | -0.222M |
| October 31, 2019 | 0.673M |
| July 31, 2019 | -0.125M |
| April 30, 2019 | 1.028M |
| January 31, 2019 | 0.714M |
| October 31, 2018 | 0.081M |
| July 31, 2018 | 0.528M |
| April 30, 2018 | -2.455M |
| January 31, 2018 | -2.439M |
| October 31, 2017 | -3.643M |
| July 31, 2017 | -3.993M |
| April 30, 2017 | -3.606M |
| January 31, 2017 | -4.164M |
| October 31, 2016 | -4.188M |
| July 31, 2016 | -6.686M |
| April 30, 2016 | -6.787M |
| January 31, 2016 | -8.085M |
| October 31, 2015 | -9.616M |
| July 31, 2015 | -9.502M |
| April 30, 2015 | -9.751M |
| January 31, 2015 | -7.68M |
| October 31, 2014 | -7.035M |
| July 31, 2014 | -4.331M |
| April 30, 2014 | -3.694M |
| January 31, 2014 | -4.904M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Medpace Holdings, Inc. | 706.69M |
| Avantor, Inc. | 454.70M |
| Personalis, Inc. | -100.98M |
| Adaptive Biotechnologies Corp. | -24.03M |
| 10X Genomics, Inc. | 121.44M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.998M |
| Cash from Investing (Quarterly) | -0.238M |
| Cash from Financing (Quarterly) | -0.019M |
| Free Cash Flow Per Share (Quarterly) | -0.1611 |
| Free Cash Flow to Equity (Quarterly) | -1.836M |
| Free Cash Flow to Firm (Quarterly) | -2.237M |
| Free Cash Flow Yield | -7.29% |